Novocure Receives FDA Approval for Second Generation Optune System
Go back to Novocure Receives FDA Approval for Second Generation Optune System| (NASDAQ: NVCR) | Delayed: 13.71 -0.57 (3.99%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.28 | 52 Week High | $28.95 | |||
| Open | $14.33 | 52 Week Low | $5.95 | |||
| Day High | $14.51 | P/E | N/A | |||
| Day Low | $13.51 | EPS | $0.00 | |||
| Volume | 1,293,106 | |||||
